| Dr Robert Daniel Cullen, MD | |
|
3100 Broadway St, Suite 509, Kansas City, MO 64111-2658 | |
| (816) 531-7373 | |
| (816) 531-1404 |
| Full Name | Dr Robert Daniel Cullen |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 24 Years |
| Location | 3100 Broadway St, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548284623 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
| Doctors Hospital Llc | Leawood, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascentist Physicians Group Llc | 9335143759 | 107 |
| Ascentist Physicians Group Llc | 9335143759 | 107 |
News Archive
The century old mission to understand how the proteins responsible for amyloid-based diseases such as Alzheimer's, Huntingdon's and Parkinson's work has taken major steps forward in the last 12 months, thanks to a revolution in a powerful microscopy technique used by scientists.
The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six-minute walking distance.
Seattle Genetics, Inc. today announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer). Under the latest relationship, Bayer will pay upfront and option exercise fees of up to $20 million for worldwide rights to utilize Seattle Genetics' auristatin-based ADC technology with antibodies to several oncology targets.
ATCC, a global leader in biological materials development, management and standards, and One Codex, a leading microbial genomics and metagenomics platform, today announced the formation of a partnership to address microbiome research needs.
Liza Makowski, PhD, professor in the Department of Medicine and the UTHSC Center for Cancer Research, has long been interested in how the immune system is altered by obesity and how this impacts cancer risk and treatment.
› Verified 2 days ago
| Entity Name | Ascentist Physicians Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649206319 PECOS PAC ID: 9335143759 Enrollment ID: O20060826000062 |
News Archive
The century old mission to understand how the proteins responsible for amyloid-based diseases such as Alzheimer's, Huntingdon's and Parkinson's work has taken major steps forward in the last 12 months, thanks to a revolution in a powerful microscopy technique used by scientists.
The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six-minute walking distance.
Seattle Genetics, Inc. today announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer). Under the latest relationship, Bayer will pay upfront and option exercise fees of up to $20 million for worldwide rights to utilize Seattle Genetics' auristatin-based ADC technology with antibodies to several oncology targets.
ATCC, a global leader in biological materials development, management and standards, and One Codex, a leading microbial genomics and metagenomics platform, today announced the formation of a partnership to address microbiome research needs.
Liza Makowski, PhD, professor in the Department of Medicine and the UTHSC Center for Cancer Research, has long been interested in how the immune system is altered by obesity and how this impacts cancer risk and treatment.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Daniel Cullen, MD 4860 College Blvd Ste 201, Overland Park, KS 66211-1681 Ph: (816) 531-7373 | Dr Robert Daniel Cullen, MD 3100 Broadway St, Suite 509, Kansas City, MO 64111-2658 Ph: (816) 531-7373 |
News Archive
The century old mission to understand how the proteins responsible for amyloid-based diseases such as Alzheimer's, Huntingdon's and Parkinson's work has taken major steps forward in the last 12 months, thanks to a revolution in a powerful microscopy technique used by scientists.
The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six-minute walking distance.
Seattle Genetics, Inc. today announced that it has entered into a new antibody-drug conjugate (ADC) collaboration with Bayer HealthCare (Bayer). Under the latest relationship, Bayer will pay upfront and option exercise fees of up to $20 million for worldwide rights to utilize Seattle Genetics' auristatin-based ADC technology with antibodies to several oncology targets.
ATCC, a global leader in biological materials development, management and standards, and One Codex, a leading microbial genomics and metagenomics platform, today announced the formation of a partnership to address microbiome research needs.
Liza Makowski, PhD, professor in the Department of Medicine and the UTHSC Center for Cancer Research, has long been interested in how the immune system is altered by obesity and how this impacts cancer risk and treatment.
› Verified 2 days ago
Dr. Kim Ann Suk Baker, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3042 | |
Dr. Bart C Patenaude, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 15 E 54th St, Kansas City, MO 64110 Phone: 816-519-3013 | |
Dr. Ann Bailey Robinson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr, Suite 450, Kansas City, MO 64114 Phone: 816-942-7200 Fax: 816-941-2767 | |
Dr. Pamela Nicklaus, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Robert Weatherly, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Joseph R Guastello, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4320 Wornall Rd, Ste 512, Kansas City, MO 64111 Phone: 816-932-8663 | |
Dr. Thomas Cotton, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |